Perflutren | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Perflutren
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Perflutren

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 7 USDMF, 2 JDMF, 1 KDMF, 1 Listed Suppliers

10 API Suppliers
7 USDMF
2 JDMF
1 KDMF
1 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

90 FDF Dossiers, 3 FDA Orange Book, 85 Europe, 1 Canada, 1 Listed Dossiers

90 FDF Dossiers
3 FDA Orange Book
85 Europe
1 Canada
1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 PMC Isochem, 1 Nanjing Well Pharmaceutical, 4 Actylis, 1 BASF, 1 Finar, 1 Kerry, 1 Pluviaendo, 1 Valens Pharmachem

1 PMC Isochem
1 Nanjing Well Pharmaceutical
4 Actylis
1 BASF
1 Finar
1 Kerry
1 Pluviaendo
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 4 Topical, 3 Film Formers & Plasticizers, 2 Solubilizers, 2 Thickeners and Stabilizers, 1 Coating Systems & Additives, 1 Emulsifying Agents, 1 Controlled & Modified Release

6 Parenteral
4 Topical
3 Film Formers & Plasticizers
2 Solubilizers
2 Thickeners and Stabilizers
1 Coating Systems & Additives
1 Emulsifying Agents
1 Controlled & Modified Release

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

60 Finished Drug Prices

60 Finished Drug Prices

MARKET PLACE

6 APIs, 8 FDF Dossiers, 1 EXCIPIENTS

6 APIs
8 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

18 US Patents, 5 Health Canada Patents

18 US Patents
5 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Torys LLP

filter Patent Reset all filters

5 All

01 12107466

02 12164845

03 12200061

04 12256592

05 12317921

filter Product Reset all filters

5 All

01 5Perflutren

filter Dosage Reset all filters

5 All

01 5gas filled lipid encapsulated microbubbles

filter Exp Date Reset all filters

5 All

01 12012-03-18

02 12014-05-20

03 12015-07-26

04 12017-06-16

05 12019-01-14

Product Main Page

01

Torys LLP

Perflutren

Antibody Engineering

Not Confirmed

Torys LLP

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-03-18

Date Granted : 2001-07-03

Brand Name : DEFINITY

Patent Number : 2107466

Filing Date : 1992-03-18

Strength per Unit : NLT 75% perfluoropropane in vial headspace

Dosage Form : gas filled lipid encapsulated microbubbles

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2012-03-18

Date Granted : 2001-07-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Torys LLP

Perflutren

Antibody Engineering

Not Confirmed

Torys LLP

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-05-20

Date Granted : 2008-04-29

Brand Name : DEFINITY

Patent Number : 2164845

Filing Date : 1994-05-20

Strength per Unit : NLT 75% perfluoropropane in vial headspace

Dosage Form : gas filled lipid encapsulated microbubbles

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2014-05-20

Date Granted : 2008-04-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Torys LLP

Perflutren

Antibody Engineering

Not Confirmed

Torys LLP

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-26

Date Granted : 2007-04-10

Brand Name : DEFINITY

Patent Number : 2200061

Filing Date : 1995-07-26

Strength per Unit : NLT 75% perfluoropropane in vial headspace

Dosage Form : gas filled lipid encapsulated microbubbles

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2015-07-26

Date Granted : 2007-04-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Torys LLP

Perflutren

Antibody Engineering

Not Confirmed

Torys LLP

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-16

Date Granted : 2010-06-01

Brand Name : DEFINITY

Patent Number : 2256592

Filing Date : 1997-06-16

Strength per Unit : NLT 75% perfluoropropane in vial headspace

Dosage Form : gas filled lipid encapsulated microbubbles

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2017-06-16

Date Granted : 2010-06-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Torys LLP

Perflutren

Antibody Engineering

Not Confirmed

Torys LLP

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-14

Date Granted : 2011-03-22

Brand Name : DEFINITY

Patent Number : 2317921

Filing Date : 1999-01-14

Strength per Unit : NLT 75% perfluoropropane in vial headspace

Dosage Form : gas filled lipid encapsulated microbubbles

Human Or VET : Human

Route of Administration : Intravenous Administration

Patent Expiration Date : 2019-01-14

Date Granted : 2011-03-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?